BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Lumonus Raises A$25 Million Series B to Accelerate Global Adoption of Its AI-Powered Oncology Workflow Platform

Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...

November 10, 2025 | News

Lunit Showcases AI-Powered Digital Pathology Breakthroughs at SITC 2025

Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-...

November 10, 2025 | News

Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation

-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...

November 07, 2025 | News

PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...

November 07, 2025 | News

NEXT Oncology Expands to Japan Through Partnership with Kansai Medical University

With continued global expansion, NEXT Oncology is one of the world’s largest Phase I Cancer Trial organizations. NEXT Oncology, an Avac...

November 07, 2025 | News

Samsung Bioepis Reaches Settlement with J&J on Stelara Biosimilar PYZCHIVA in Europe

Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of PYZCHIVA®, a bio...

November 07, 2025 | News

Asahi Kasei’s Nefecon Included in KDIGO 2025 Guideline for IgA Nephropathy Management

Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonid...

November 06, 2025 | News

Avant Technologies and SGAustria Form Joint Venture to Pioneer Stem Cell–Based Diabetes Therapies

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), ...

November 06, 2025 | News

Takeda’s QDENGA Trial Confirms Sustained Protection and Favourable Safety Over Seven Years

Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the ...

November 06, 2025 | News

Novo Nordisk Launches Wegovy® in Hong Kong to Tackle Rising Obesity Rates with Proven Long-Term Weight Management Therapy

Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical a...

November 04, 2025 | News

AmeriWater Launches Capsule System — Industry’s First Single-Skid Water Purification and Distribution Solution

AmeriWater, a leading provider of advanced water purification systems for healthcare, announced it has launched the industry's only single skid solution ...

November 04, 2025 | News

Lonza to Acquire Redberry SAS, Advancing Rapid Microbiology Testing with Solid-Phase Cytometry Technology

Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced that it has signed an agreement to acquire ...

October 31, 2025 | News

Myrio Therapeutics Partners with University of Pennsylvania and NYU Langone to Advance Next-Generation T Cell Immunotherapies

Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to...

October 29, 2025 | News

Raffles Medical Group and Gene Solutions Partner to Expand Access to Oncology Clinical Trials Across Southeast Asia

Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streaml...

October 28, 2025 | News

Stay Connected